Achillion Pharmaceuticals, Inc. (ACHN) Posts Q1 Loss of 17c/Share

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown